GSK plc (LON:GSK) Receives Average Recommendation of "Hold" from Analysts

GSK plc (LON:GSK - Get Free Report) has earned a consensus recommendation of "Hold" from the seven brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is GBX 1,630.63 ($20.64).

A number of brokerages have weighed in on GSK. Berenberg Bank boosted their price target on GSK from GBX 1,650 ($20.88) to GBX 1,820 ($23.04) and gave the stock a "buy" rating in a research report on Wednesday, February 14th. Barclays reiterated an "equal weight" rating and issued a GBX 1,725 ($21.83) price target on shares of GSK in a research note on Monday, April 8th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 1,950 ($24.68) price target on shares of GSK in a research note on Tuesday, March 12th. Finally, Shore Capital restated a "buy" rating on shares of GSK in a research note on Thursday, March 7th.

Insider Transactions at GSK

In related news, insider Emma Walmsley sold 139,792 shares of the firm's stock in a transaction dated Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.98), for a total value of £2,317,751.36 ($2,933,491.15). In other news, insider Emma Walmsley sold 139,792 shares of the firm's stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.98), for a total transaction of £2,317,751.36 ($2,933,491.15). Also, insider Urs Rohner purchased 434 shares of the firm's stock in a transaction dated Wednesday, March 20th. The shares were bought at an average price of GBX 1,662 ($21.04) per share, with a total value of £7,213.08 ($9,129.33). Insiders have purchased 19,802 shares of company stock valued at $31,381,484 in the last 90 days. 1.71% of the stock is currently owned by corporate insiders.

GSK Stock Up 0.9 %

Shares of LON:GSK traded up GBX 14.50 ($0.18) during midday trading on Friday, reaching GBX 1,643.50 ($20.80). The company had a trading volume of 4,346,402 shares, compared to its average volume of 7,201,768. The company has a quick ratio of 0.73, a current ratio of 0.88 and a debt-to-equity ratio of 140.82. The business's 50 day moving average price is GBX 1,666.63 and its 200 day moving average price is GBX 1,542.86. The stock has a market cap of £67.22 billion, a PE ratio of 1,369.58, a P/E/G ratio of 1.09 and a beta of 0.27. GSK has a 1-year low of GBX 1,302.60 ($16.49) and a 1-year high of GBX 1,719.80 ($21.77).

GSK Increases Dividend

The business also recently disclosed a dividend, which was paid on Thursday, April 11th. Stockholders of record on Thursday, February 22nd were given a dividend of GBX 16 ($0.20) per share. This represents a dividend yield of 1.04%. The ex-dividend date of this dividend was Thursday, February 22nd. This is a boost from GSK's previous dividend of $14.00. GSK's dividend payout ratio is 5,333.33%.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.